Nobilis Health Receives Final Approval to List on NEO

NEO Prepares to Welcome Its First Cross-Border Listing

TORONTO--()--The NEO Exchange (“NEO”) is pleased to announce that Nobilis Health Corp. (NYSE American:HLTH) (“Nobilis Health”) has received final approval to list its common shares on NEO. Nobilis Health will be the first corporation to list its shares on both a US-based stock exchange and NEO. Nobilis Health shares are expected to begin trading on NEO on March 7, 2018.

“We are pleased to have received approval to list on NEO and are eagerly anticipating our return to the Canadian market,” stated Harry Fleming, Nobilis Health CEO and Chairman of the Board. “Better access to and by investors, enabled by a dual listing in the US and Canada, will benefit our existing shareholders and our ability to raise capital in the future. NEO’s unique focus on quality liquidity and its investor outreach program will further the recognition of our true market value and allow us to grow our Canadian shareholder base. The first-rate service offered by NEO and their depth of knowledge have helped expedite this cross-listing process. We are excited about the impact this will have on our global shareholder base.”

Nobilis Health, a leading US healthcare development and management company with over 30 locations across Texas and Arizona, including hospitals, ambulatory surgery centres, multi-specialty clinics and partners with over 30 facilities across the country, generated over USD $285 million in revenue in 2016.

“We believe that tangible, long-term benefits for global investors and international companies like Nobilis Health can be realized through a dual listing, and are proud that our commitment to doing things differently in the stock exchange business is what will rekindle their relationship with the Canadian capital markets,” added Jos Schmitt, President and Chief Executive Officer, NEO. “Our stock exchange is designed to meet the needs of public companies like Nobilis Health who recognize both the opportunities the Canadian capital markets can bring to their growth strategy and the opportunities international companies can bring to Canadian investors and the Canadian economy as a whole. We look forward to welcoming Nobilis Health back to Canada this week.”

When shares begin trading on Wednesday under the ticker symbol HLTH, Nobilis Health (www.NobilisHealth.com) will become the first cross-listed company on NEO.

To learn more, or inquire about listing or trading on NEO, please contact NEO’s Investor Helpline at 1-844-567-6424 (toll-free) or visit: https://www.aequitasneo.com/en/home.

About NEO Exchange

The NEO Exchange (NEO) is Canada’s next generation stock exchange, putting the needs of investors, businesses looking to raise capital and dealers first. Launched in March 2015, the NEO Exchange currently offers an innovative trading venue to trade all Canadian securities. It also has a value added listing platform for capital raising companies and investment products, offering unique liquidity, transparency and efficiency benefits. For more information, please visit: NEOstockexchange.com.

Join us on social media: twitter | linkedin | facebook

Contacts

The NEO Exchange
Adam Bornstein, 905-505-2540
adam@NEOstockexchange.com

Release Summary

NEO is pleased to announce that Nobilis Health Corp. (NYSE American: HLTH) has received final approval to list its common shares on the NEO Exchange.

Contacts

The NEO Exchange
Adam Bornstein, 905-505-2540
adam@NEOstockexchange.com